Vanda Pharmaceuticals Inc. (VNDA) Insider Trading Activity

NASDAQ$3.835+0.08 (2.13%)
Market Cap
$226.76M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
827 of 849
Rank in Industry
477 of 491

VNDA Insider Trading Activity

VNDA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$2,824,768
6
100

Related Transactions

Honore Tagedirector
0
$0
1
$240,900
$-240,900
Wijkstrom JoakimSVP, Chief Marketing Officer
0
$0
1
$254,590
$-254,590
Birznieks GuntherSVP, Business Development
0
$0
1
$350,730
$-350,730
Williams TimothySVP & General Counsel
0
$0
1
$350,755
$-350,755
Moran Kevin PatrickSVP, CFO & Treasurer
0
$0
1
$350,821
$-350,821
Polymeropoulos Mihael HristosPresident and CEO
0
$0
1
$1.28M
$-1.28M

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic solutions that address critical unmet medical needs. The company currently offers two approved treatments: HETLIOZ, prescribed for non-24-hour sleep-wake disorders, and Fanapt oral tablets, used in the management of schizophrenia. Vanda maintains an active and diverse development pipeline, exploring new applications for its existing therapies and advancing a range of novel compounds. This includes expanding HETLIOZ (tasimelteon) to …

Insider Activity of Vanda Pharmaceuticals Inc.

Over the last 12 months, insiders at Vanda Pharmaceuticals Inc. have bought $0 and sold $2.82M worth of Vanda Pharmaceuticals Inc. stock.

On average, over the past 5 years, insiders at Vanda Pharmaceuticals Inc. have bought $513,636 and sold $1.64M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 10,000 shares for transaction amount of $41,500 was made by Polymeropoulos Mihael Hristos (President and CEO) on 2025‑08‑07.

List of Insider Buy and Sell Transactions, Vanda Pharmaceuticals Inc.

2026-03-02SalePolymeropoulos Mihael HristosPresident and CEO
156,235
0.2425%
$8.17
$1.28M
-27.78%
2026-03-02SaleBirznieks GuntherSVP, Business Development
42,431
0.0666%
$8.27
$350,730
-27.78%
2026-03-02SaleMoran Kevin PatrickSVP, CFO & Treasurer
42,442
0.0666%
$8.27
$350,821
-27.78%
2026-03-02SaleWilliams TimothySVP & General Counsel
42,434
0.0666%
$8.27
$350,755
-27.78%
2026-03-02SaleWijkstrom JoakimSVP, Chief Marketing Officer
30,800
0.0483%
$8.27
$254,590
-27.78%
2026-02-23SaleHonore Tagedirector
30,000
0.05%
$8.03
$240,900
-26.93%
2025-08-07PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0167%
$4.15
$41,500
+45.24%
2025-06-13SaleMitchell Stephen Raydirector
7,000
0.0121%
$4.59
$32,130
+33.26%
2025-05-21PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0173%
$4.40
$43,995
+24.07%
2025-05-16PurchasePolymeropoulos Mihael HristosPresident and CEO
20,000
0.0345%
$4.22
$84,472
+28.00%
2025-03-06PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0176%
$5.01
$50,150
-2.85%
2025-03-05PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0169%
$5.02
$50,200
-7.02%
2025-03-03PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0172%
$4.71
$47,050
+1.06%
2025-02-28PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0171%
$4.76
$47,600
+0.10%
2025-02-27PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0172%
$4.76
$47,600
+1.28%
2025-02-26PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0174%
$4.76
$47,650
+1.06%
2025-02-25PurchasePolymeropoulos Mihael HristosPresident and CEO
10,000
0.0173%
$4.46
$44,640
+6.73%
2025-02-21PurchaseMoran Kevin PatrickSVP, CFO & Treasurer
2,000
0.0034%
$4.39
$8,779
+7.11%
2024-11-14SaleMitchell Stephen Raydirector
5,000
0.0086%
$5.17
$25,863
-9.61%
2024-07-29SaleMoran Kevin PatrickSVP, CFO & Treasurer
2,251
0.0038%
$5.92
$13,327
-21.50%
Total: 304
*Gray background shows transactions not older than one year

Insider Historical Profitability

7.1%
Polymeropoulos Mihael HristosPresident and CEO
2704496
4.4725%
$10.14M1553
+6.13%
Moran Kevin PatrickSVP, CFO & Treasurer
411380
0.6803%
$1.54M115
+7.11%
TANG KEVIN C10 percent owner
2715852
4.4913%
$10.18M68
Flynn James E10 percent owner
693171
1.1463%
$2.6M55
+15.47%
Kelly James PatrickEVP & Chief Financial Officer
186869
0.309%
$700,758.75114
<0.0001%
Clark William DSr. VP, Chief Business Officer
168279
0.2783%
$631,046.25110
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$22,710,871
107
8.53%
$220.62M
$6,146,922
96
-4.70%
$233.68M
$19,239,249
50
-2.24%
$238.33M
$168,352,523
35
13.58%
$218.79M
$3,668,031
23
2.05%
$243.03M

VNDA Institutional Investors: Active Positions

Increased Positions68+34.69%6M+14.26%
Decreased Positions87-44.39%9M-20.91%
New Positions29New3MNew
Sold Out Positions25Sold Out5MSold Out
Total Postitions177-9.69%42M-6.66%

VNDA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$73,576.0015.12%8.92M-517,321-5.48%2025-09-30
Vanguard Group Inc$29,594.006.08%3.59M+14,336+0.4%2025-09-30
Renaissance Technologies Llc$28,685.005.89%3.48M+29,465+0.85%2025-09-30
Millennium Management Llc$26,819.005.51%3.25M+130,497+4.18%2025-09-30
Dimensional Fund Advisors Lp$21,153.004.35%2.56M-21,788-0.84%2025-09-30
Tang Capital Management Llc$19,415.003.99%2.35M00%2025-09-30
Acadian Asset Management Llc$18,387.003.78%2.23M+496,854+28.69%2025-09-30
Geode Capital Management, Llc$11,485.002.36%1.39M-299,553-17.71%2025-09-30
State Street Corp$10,486.002.15%1.27M+5,232+0.41%2025-09-30
Krensavage Asset Management, Llc$9,738.002%1.18M+155,505+15.17%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.